Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Clinical trial NCT00194714 · COMPLETED

Trial details

NCT number: NCT00194714
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2/Neu Positive HLA-A2 Positive Cells Present Stage IV Breast Cancer Stage IV Ovarian Cancer

Start date: 2016-05-01
Primary completion: 2021-03-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.